Treatment of visceral leishmaniasis in children in the Central-West Region of Brazil

Infection

Volumn 38, Issue 4, 2010, Pages 261-267

  Brustoloni, Y M ^a   Cunha, R V ^a   Consolo L Z ^a   Oliveira, A L L ^a   Dorval, M E C ^a   Oshiro, E T ^a  

^a FEDERAL UNIVERSITY OF MATO GROSSO DO SUL   (Brazil)

Author keywords

Children; Treatment; Visceral leishmaniasis

Indexed keywords

ALBUMIN; AMPHOTERICIN B; AMPHOTERICIN B CHOLESTEROL SULFATE; ANTIBIOTIC AGENT; FRESH FROZEN PLASMA; MEGLUMINE ANTIMONATE;

ABDOMINAL PAIN; ACUTE OTITIS MEDIA; ADOLESCENT; ALLERGIC CONJUNCTIVITIS; AMINOTRANSFERASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ARTHRALGIA; ARTICLE; BLEEDING; BRAZIL; CHILD; CHILL; CONTROLLED STUDY; CYANOSIS; DRUG EFFICACY; DRUG FATALITY; DRUG FEVER; DRUG OVERDOSE; ELECTROCARDIOGRAPHY; ERYTHROCYTE TRANSFUSION; EYE DISEASE; FEMALE; HUMAN; HYPOALBUMINEMIA; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NAUSEA; NEUROLOGIC DISEASE; NYSTAGMUS; OUTCOME ASSESSMENT; PANCREATITIS; PEDIATRICS; PNEUMONIA; PRESCRIPTION; QT INTERVAL; RETROSPECTIVE STUDY; SIDE EFFECT; ST SEGMENT ELEVATION; T WAVE INVERSION; THROMBOCYTE TRANSFUSION; TREATMENT RESPONSE; TREMOR; VISCERAL LEISHMANIASIS; VOMITING;

ADOLESCENT; ANTIPROTOZOAL AGENTS; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 77956057593     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-010-0022-3     Document Type: Article

References (23)

1. HC Maltezou 2008 Visceral leishmaniasis: advances in treatment Recent Pat Antiinfect Drug Discov 3 192 198 10.2174/157489108786242341 1:CAS:528:DC%2BD1MXjtVyktbo%3D 18991801
2. L Kedzierski A Sakthianandeswaren JM Curtis PC Andrews PC Junk K Kedzierska 2009 Leishmaniasis: current treatment and prospects for new drugs and vaccines Curr Med Chem 16 599 614 10.2174/092986709787458489 1:CAS:528:DC%2BD1MXjsFGqsbo%3D 19199925
3. Y Mueller A Nguimfack P Cavailler S Couffignal JB Rwakimari L Loutan F Chappuis 2008 Safety and effectiveness of amphotericin B deoxycholate for the treatment of visceral leishmaniasis in Uganda Ann Trop Med Parasitol 102 11 19 10.1179/136485908X252142 1:CAS:528:DC%2BD1cXisVOhtbo%3D 18186974
4. J Berman 2003 Current treatment approaches to leishmaniasis Curr Opin Infect Dis 16 397 401 10.1097/00001432-200310000-00005 1:CAS:528: DC%2BD3sXnsVKis74%3D 14501991
5. C Bern J Adler-Moore J Berenguer M Boelaert M den Boer RN Davidson C Figueras L Gradoni DA Kafetzis K Ritmeijer E Rosenthal C Royce R Russo S Sundar J Alvar 2006 Liposomal amphotericin B for the treatment of visceral leishmaniasis Clin Infect Dis 43 917 924 10.1086/507530 1:CAS:528: DC%2BD28XhtVKhsrbN 16941377
6. P Minodier S Robert G Noël P Blanc K Retornaz JM Garnier 2005 Amphotéricine B liposomale en première intention dans la leishmaniose viscérale infantile en région Provence-Alpes- Côte-d'Azur-Corse (First-line liposomal amphotericin B for pediatric visceral leishmaniasis in southern France) Arch Pediatr 12 1102 1108 10.1016/j.arcped.2005.01.009 1:STN:280:DC%2BD2MzhsFSksg%3D%3D 15964525
7. HW Murray JD Berman CR Davies NG Saravia 2005 Advances in leishmaniasis Lancet 366 1561 1577 10.1016/S0140-6736(05)67629-5 1:CAS:528:DC%2BD2MXhtFKhsbfK 16257344
8. E Palumbo 2008 Oral miltefosine treatment in children with visceral leishmaniasis: a brief review Braz J Infect Dis 12 2 4 1:CAS:528: DC%2BD1cXht1yisLrI 18553005
9. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Coordenação Geral de Vigilância Epidemiológica. Leishmaniose Visceral Grave. Normas e Condutas. Brasília: Ministério da Saúde, 2006.
10. Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde. Departamento de Vigilância Epidemiológica. Manual de vigilância e controle da leishmaniose visceral. Brasília: Ministério da Saúde, 2003.
11. JD Chulay HC Spencer M Mugambi 1985 Electrocardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate) Am J Trop Med Hyg 34 702 709 1:STN:280:DyaL2M3ns12hsw%3D%3D 2992303
12. Oliveira-Neto MP, Mattos M, Pirmez C, Fernandes O, Gonçalves-Costa SC, Souza CF, et al. Mucosal leishmaniasis (espundia) responsive to low dose of N-methyl glucamine (Glucantime) in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo. 2000;42:321-5.
13. A Masmoudi N Maalej M Mseddi A Souissi H Turki S Boudaya S Bouassida A Zahaf 2005 Glucantime par voie parentérale: bénéfice versus toxicité Méd Mmal Infect 35 42 45 10.1016/j.medmal.2004.07.032 1:STN:280:DC%2BD2M7mtlOnsg%3D%3D
14. ALL Oliveira YM Brustoloni TD Fernandes ME Dorval RV da Cunha MN Bóia 2009 Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil Trop Doct 39 180 182 10.1258/td.2008.080369 19535762
15. C Rapp F Simon ML Dordain 2000 L'antimoniate de N-méthyl glucamine, ou Glucantime Med Trop (Mars) 60 342 343 1:STN:280: DC%2BD3MznvF2ksg%3D%3D
16. N Kuyucu C Kara A Bakirtaç T Teziç 2001 Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate Ped Infect Dis J 20 455 457 10.1097/00006454-200104000-00021 1:STN:280:DC%2BD3MvkvVarug%3D%3D
17. Ribeiro AL, Drummond JB, Volpini AC, Andrade AC, Passos VM. Electrocardiographic changes during low-dose, short-term therapy of cutaneous leishmaniasis with the pentavalent antimonial meglumine. Braz J Med Biol Res. 1999;32:297-301.
18. EA Khalil AE Ahmed AM Musa MH Hussein 2006 Antimony-induced cerebellar ataxia Saudi Med J 27 90 92 16432602
19. MA Santos RC Marques CA Farias DM Vasconcelos JM Stewart DL Costa CH Costa 2002 Predictors of an unsatisfactory response to pentavalent antimony in the treatment of American visceral leishmaniasis Rev Soc Bras Med Trop 35 629 633 12612746
20. S Sundar 2001 Drug resistance in Indian visceral leishmaniasis Trop Med Int Health 6 849 854 10.1046/j.1365-3156.2001.00778.x 1:STN:280: DC%2BD3MnltFOqsQ%3D%3D 11703838
21. HC Maltezou C Siafas M Mavrikou P Spyridis C Stavrinadis T Karpathios DA Kafetzis 2000 Visceral leishmaniasis during childhood in southern Greece Clin Infect Dis 31 1139 1143 10.1086/317455 1:STN:280:DC%2BD3M%2FotVSnuw%3D%3D 11073742
22. B Benjamin SH Annobil WA Bassuni 1994 Diagnostic and management problems in childhood visceral leishmaniasis in south-western Saudi Arabia Ann Trop Paediatr 14 7 13 1:STN:280:DyaK2c3ntVOrtQ%3D%3D 7516138
23. GL Werneck MS Batista JR Gomes DL Costa CH Costa 2003 Prognostic factors for death from visceral leishmaniasis in Teresina, Brazil Infection 31 174 177 1:STN:280:DC%2BD3s3mtFyjtQ%3D%3D 12789476